(Oslo, January 3rd, 2020) Medistim ASA (OSE: MEDI), a niche market leader within
ultrasound technology with headquarter in Norway, that develops and
commercializes medical equipment for use within cardiac, vascular and transplant
surgery, announces that the company from now on will inform the market in
English.

Medistim has submitted an application to the Oslo Stock Exchange and
Skatteetaten (The Norwegian Tax Administration) with a request to obtain an
exemption to send stock exchange notices, as well as to prepare annual reports
in English language only. Since the company's operations are internationally
oriented, the working language and the industry language is English. In
addition, the company communicates with investors and other key players mainly
in English. On this basis, Medistim is granted an exemption to report and inform
the market in English language only, and all information from Medistim will from
now on be in English.

About Medistim:
Medistim was established in 1984, and has a track record of profitable growth
over the past >15 years.  The company is a pioneer within its segment, and
continues to invest in new product development.  Medistim has wholly owned
subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark
and Norway, in addition to the about 50 distributors in Europe, Asia, Middle
East, Africa, Canada and South America.   For more information, visit the
Medistim home page:  www.Medistim.com 

This information is disclosed under Norwegian law (Verdipapirhandelloven §5-12).

For more information, contact: 
President and CEO, Kari E. Krogstad, Medistim ASA 
Tel: + 47 918 38 110  
Email: kari.krogstad@medistim.com 
CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940  
Email: thomas.jakobsen@medistim.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange